Browsing by Author Duric, Vlatka

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
Issue DateTitleAuthor(s)Citation
2010Adjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile?Beale, Philip; Blinman, Prunella; Clarke, Stephen; Duric, Vlatka; Hudson, Malcolm; Stockler, Martin; Boyce, Adam; Briscoe, Karen; Goldstein, David; Nowak, Anna K.; Central Clinical School: Medicine; School of Public Health: Public Health; Northern Clinical School: Kolling Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAdjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile?, European Journal of Cancer, vol.46, 10, 2010,pp 1800-1807
2005Comparing patients' and their partners' preferences for adjuvant chemotherapy (ACT) in early breast cancer (EBC)Beith, Jane; Boyle, Frances; Butow, Phyllis; Coates, Alan; Duric, Vlatka; Heritier, Stephane; Sharpe, Louise; Simes, Robert John; Stockler, Martin; Wilcken, Nicholas; Central Clinical School: Medicine; Central Clinical School: Medicine; Psychology; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Comparing patients' and their partners' preferences for adjuvant chemotherapy (ACT) in early breast cancer (EBC), Journal of Clinical Oncology (Print), vol.23,(16S),2005,pp 546S-546S
2008Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancerButow, Phyllis; Coates, Alan; Duric, Vlatka; Heritier, Stephane; Sharpe, Louise; Simes, Robert John; Stockler, Martin; Beith, Jane M.; Boyle, Frances; Wilcken, Nocholas; Psychology; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; The George Institute for Global Health; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreComparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer, Patient Education and Counseling, vol.72, 2, 2008,pp 239-245
2006The European Organization for Research and Treatment of Cancer (EORTC) quality-of-life questionnaire cervical cancer module - EORTC QLQ-CX24.Duric, Vlatka; Chie, Weichu; Greimel, Elfriede R.; Jensen, Pernille T.; Nordin, Andy; Radisic, Vesna Bjelic; Singer, Susanne; Vlasic, Karin Kuljanic; Waldenstrom, Ann-Charlotte; Wydra, Dariusz; School of Public Health: NH&MRC Clinical Trials CentreThe European Organization for Research and Treatment of Cancer (EORTC) quality-of-life questionnaire cervical cancer module - EORTC QLQ-CX24., Cancer 2005, vol.107,(8),2006,pp 1812-1822
2011Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: What makes it worthwhile?Blinman, Prunella; Brown, Christopher; Duric, Vlatka; Stockler, Martin; Fong, K; McLachlan, Sue-Anne; Millward, Michael; Nowak, Anna K.; Wright, Gavin; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreLung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: What makes it worthwhile?, Lung cancer, vol.72, 2, 2011,pp 213-218
2005Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?Beith, Jane; Boyle, Frances; Coates, Alan; Duric, Vlatka; Heritier, Stephane; Simes, Robert John; Stockler, Martin; Sullivan, Anne; Wilcken, Nicholas; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: General Practice; Western Clinical School: Medicine (Westmead)Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?, Annals of Oncology, vol.16,(11),2005,pp 1786-1794
2005Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile?Coates, Alan; Duric, Vlatka; Stockler, Martin; Fallowfield, L. J.; Houghton, J.; Saunders, C.; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePatients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile?, British Journal of Cancer, vol.93,(12),2005,pp 1319-1323
2010Patients' preferences for chemotherapy in non-small-cell lung cancer: A systematic review.Blinman, Prunella; Duric, Vlatka; Stockler, Martin; Alam, Mahmood; McLachlan, Sue Anne; Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePatients' preferences for chemotherapy in non-small-cell lung cancer: A systematic review., Lung cancer, vol.69, 2,pp 2010-141
2004Predictors of the benefits women consider necessary to make adjuvant chemotherapy (ACT) worthwhile for early breast cancer (EBC)Beith, Jane; Boyle, Frances; Butow, Phyllis; Coates, Alan; Dhillon, Haryana; Duric, Vlatka; Sharpe, Louise; Simes, Robert John; Stockler, Martin; Sullivan, Anne; Central Clinical School: Medicine; Central Clinical School: Medicine; Psychology; School of Public Health: Public Health; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: General PracticePredictors of the benefits women consider necessary to make adjuvant chemotherapy (ACT) worthwhile for early breast cancer (EBC), Journal of Clinical Oncology (Print), vol.22, 14S,pp 73S-73S
2007Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer.Butow, Phyllis; Coates, Alan; Duric, Vlatka; Heritier, Stephane; Sharpe, Louise; Simes, Robert John; Stockler, Martin; Beith, Jane M.; Boyle, Frances; Wilcken, Nocholas; Psychology; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePsychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer., Psycho-Oncology, vol.16,(1),2007,pp 48-59
2003Reducing psychological distress in a genetic counseling consultation for breast cancerBarratt, Alexandra; Butow, Phyllis; Duric, Vlatka; Lobb, Elizabeth; Sharpe, Louise; Meiser, Bettina; Tucker, Katherine M.; School of Public Health: Public Health; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; PsychologyReducing psychological distress in a genetic counseling consultation for breast cancer, Journal of Genetic Counseling, vol.12,(3),2003,pp 243-264
2005What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?Boyle, Frances; Duric, Vlatka; Stockler, Martin; Stuart-Harris, Robin; Wilcken, Nicholas; Beith, Jane M.; Friedlander, Michael; Links, Matthew; McLachlan, Sue Anne; Meiser, Bettina; Phillips, Kelly-Anne; Taylor, Alan; Thewes, Belinda; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Medicine; Western Clinical School: Medicine (Westmead)What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?, Lancet Oncology, vol.6,(8),2005,pp 581-588